What is Altimmune's retained earnings?

Altimmune (ALT) reported retained earnings of -$672.05M in Q1 2026.

How has Altimmune's retained earnings changed year-over-year?

Altimmune's retained earnings decreased by 15.7% year-over-year, from -$580.97M to -$672.05M.

What is the long-term trend for Altimmune's retained earnings?

Over 5 years (2020 to 2025), Altimmune's retained earnings has grown at a 28.4% compound annual growth rate (CAGR), from -$186.42M to -$649.48M.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Altimmune ALT Retained Earnings

Retained Earnings at other companies

Eli LillyLLY

$29.51B+95.5%

Merck & Co.MRK

$66.72B+0.9%

Madrigal Pharmaceuticals, Inc.MDGL

-$2.18B-16.5%

Viking TherapeuticsVKTX

-$1.01B-88.5%

Wave Life SciencesWVE

-$1.35B-15.7%

Delcath SystemsDCTH

-$529.92M+0.1%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's retained earnings?: Altimmune (ALT) reported retained earnings of -$672.05M in Q1 2026.
How has Altimmune's retained earnings changed year-over-year?: Altimmune's retained earnings decreased by 15.7% year-over-year, from -$580.97M to -$672.05M.
What is the long-term trend for Altimmune's retained earnings?: Over 5 years (2020 to 2025), Altimmune's retained earnings has grown at a 28.4% compound annual growth rate (CAGR), from -$186.42M to -$649.48M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.